FTC sues main pharmacy reward professionals over insulin prices The company introduced action versus Caremark, Categorical Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating techniques “artificially inflated” the record price of daily life-saving insulin drugs. Elevance lowers direction on ‘unprecedented’ Medicaid worries Executives mentioned the enhanced expens... https://arizona-hard-nutrition-fa71615.buyoutblog.com/30681794/the-smart-trick-of-healthcare-news-that-no-one-is-discussing